Low-Cost Sensor Detects Parkinson’s Earlier in Biological Samples
The sensor was fabricated using a 3D printer and was capable of early diagnosis, also serving as a model for identifying other diseases.
Read MorePosted by Andy Lundin | Apr 13, 2023 | Disease States |
The sensor was fabricated using a 3D printer and was capable of early diagnosis, also serving as a model for identifying other diseases.
Read MorePosted by Andy Lundin | Apr 12, 2023 | Sequencing Systems |
Centogene launched an enhanced next-generation sequencing (NGS)-based assay, for rare and neurodegenerative diseases.
Read MorePosted by Andy Lundin | Apr 10, 2023 | Dementias & Alzheimer’s |
C2N Diagnostic’s blood test matches up in amyloid detection to CSF testing and amyloid PET in a study of patients with cognitive impairment.
Read MorePosted by Andy Lundin | Jan 12, 2023 | Company News, Diagnostic Technologies |
Helix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MorePosted by Chris Wolski | Dec 28, 2022 | Dementias & Alzheimer’s |
Researchers have developed a blood biomarker test to detect a novel marker of Alzheimer’s disease neurodegeneration in a blood sample.
Read More